Delivery Order SPE2DB20D1004-SPE2DB24FG6G6
Award Date
8/8/24
Potential Completion Date
8/9/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,018.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,967,900 units of the prescription medication Vyvanse 70 mg capsules. The contract is a delivery order, with a firm fixed price and an ultimate completion date of April 21, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $3,522.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,234,067 units of the prescription medication Vyvanse 30 mg capsules. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 14, 2025. It is not designated as a set-aside contract, indicating open...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
This federal contract award, valued at $2,563.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,880,875 units of the prescription drug Vyvanse 30 mg capsules. The contract is a Firm Fixed Price Delivery Order, with a completion date of June 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $4,788.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,072,761 units of the prescription medication Vyvanse 30 mg capsules. The award is a delivery order contract with a firm fixed price and an ultimate completion date of April 29, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,738.42 firm fixed-price delivery order is for the supply of Vyvanse 30 mg capsules, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $2,006.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of 4,567,951,705 units of the medication Vyvanse 30 mg capsules. The contract is not set aside and is a firm fixed-price, non-IDV (Indefinite Delivery Vehicle) award. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,533.10 delivery order contract is for the supply of Vyvanse 30mg capsules to support the DLA's medical supply needs. The contract is a firm fixed-price type with a period of performance through July 27, 2022. It was not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $4,403.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,165,601 units of the prescription medication Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a $1,944.37 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,535,294 units of the prescription medication Vyvanse 30 mg capsules. The contract has a period of performance through June 13, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...